Phosphoinositide 3-kinase δ (PI3Kδ), a lipid kinase consisting of a catalytic (p110δ, encoded by PIK3CD) and a regulatory subunit (p85, encoded by PIK3R1), generates the second messenger phosphatidylinositol (3,4,5)-trisphosphate (PIP 3 ) in the plasma membrane of leukocytes downstream of antigen and cytokine receptors. 1 Signaling via PDK1, AKT, mTOR and downstream targets such as FOXO1, contributes to the metabolic and transcriptional changes required for the expansion, differentiation and effector function of lymphocytes. 1 Activating germline mutations in PIK3CD cause the immune dysregulatory disease activated PI3Kδ syndrome (APDS), usually presenting with recurrent sinopulmonary infections in childhood, herpesvirus infections and CD4 + lymphopenia, underscoring the important role of balanced p110δ activity in human adaptive immunity. 1, 2 Ablation of p110δ in mice leads to aberrant T cell responses and intestinal inflammation. 3, 4 In humans, immune dysregulation including severe colitis is present in many cancer patients who are treated with the p110δ-specific inhibitor Idelalisib. 5 Recently, one patient with autosomal recessive deficiency of p85α 6 and two patients with loss-of function mutations in p110δ 7 have been described who developed humoral immunodeficiency and colitis.
We report a child of consanguineous parentage ( fig.1A ) who presented at 9 years with bruising and upper gastrointestinal bleeding in association with profound immune-mediated thrombocytopenia. His thrombocytopenia was refractory to corticosteroids, high dose immunoglobulin and splenectomy, culminating in an intracranial bleed requiring surgical evacuation. Immunosuppression was then intensified with cyclosporine, azathioprine and a course of the B-cell-depleting agent Rituximab, with eventual platelet recovery. However, over the next few months he developed first a severe pneumonia followed by intractable diarrhea and striking (~30%) weight loss. Endoscopy (supplementary table 1 ).
The patient was treated with total parenteral nutrition and an empiric combination of antiinflammatory (mesalazine) and antiviral (ganciclovir, foscarnet) therapy, but continued with torren-tial diarrhoea (3L/day) until the addition of immunosuppression (corticosteroid, cyclosporine, infliximab In accordance with the expected role of PI3Kδ and absence of full-length protein expression ( fig.   2A ), patient-derived T lymphoblasts were profoundly impaired in their ability to generate PIP 3 upon TCR engagement ( fig.2B ). TCR-and IL-2-induced phosphorylation of AKT was also reduced in CD4 + and CD8 + T lymphoblasts, as was IL-2-induced phosphorylation of the mTOR target S6
( fig.2A and supplementary fig.2 ). Glycolysis stress test showed impaired IL-2-stimulated glycolysis and glycolytic reserve in patient cells, similar to the behaviour of CD4 + and CD8 + T cells treated with Idelalisib ( fig.2C-D) . These findings show that germline p110δ deficiency impairs lymphocyte metabolism, which we hypothesised might contribute to immunodysregulation through altered T cell polarization and behaviour.
To investigate the cellular immunophenotype within the patient's inflamed gut, we performed immunohistochemistry on colonic biopsies taken prior to HSCT. Relative to healthy age-matched control tissue, there was a modest expansion of CD8 + T cells in the lamina propria and a decrease in the CD4 + to CD8 + T cell ratio (supplementary fig.3 ). Additionally, we observed a substantial increase in lymphocytes expressing the transcription factor TBET and perforin within both CD8 + and CD8 -T cell compartments ( supplementary fig.4 ).
Owing to the paucity of patient material we were unable to assess directly the function of specific leukocyte subsets but mouse models of PI3Kδ deficiency imply wide-ranging impairments of Tregulatory function, B cell help and CD8 + T cell memory. 3, 4 Similar to our patient, p110δ kinasedead mice spontaneously develop inflammatory bowel disease with crypt abscesses. 3 In these mice, thymic output of Tregs was normal, but Treg trafficking and suppressive activity including IL-10 secretion were disturbed. 4 p110δ kinase-dead mice make weaker responses to antigen exposure than WT mice, both in vivo and in vitro 3, 8 , despite apparently normal proliferation and metabolic reprogramming of CD8 + T cells after stimulation of the TCR and the IL-2 receptor 9, 10 . Secretion of IFN-γ by effector/memory CD8 + T cells was however significantly reduced by inhibitors of p110δ 11 and AKT 9 , consistent with reduced production of IFN-γ in patient cells and potentially relevant to viral susceptibility. This primary immunodeficiency thus highlights the central importance of regulated PI3Kδ activity for immune homeostasis and protective immunity in humans as in mice.
Germline autosomal recessive deficiency of PIK3CD has recently been reported in a total of 3 kindreds (supplementary table 3), though two siblings had a second concurrent immune disorder, complicating interpretation of their phenotype 7, 12, 13 . Of the remaining four patients, all presented with hypogammaglobulinemia and recurrent sinopulmonary infections, some including severe and opportunistic pneumonias. Immune dysregulatory phenomena were also frequent, including inflammatory bowel disease, autoimmune hepatitis and juvenile idiopathic arthritis. Their management involved immunoglobulin replacement and antimicrobial therapy for acute infections, together with anti-inflammatory (mesalazine) or immunosuppressive (steroids and 6-mercaptopurine) therapy where indicated for autoimmune complications. 7, 12, 13 Although B and NK cell numbers were very low in some patients, others had normal counts and standard laboratory measures of T cell number and function were generally unremarkable. Therefore a high index of suspicion for an underlying monogenic cause is required in this setting.
In summary, we report a child with homozygous germline loss-of-function mutation in PIK3CD, who developed refractory immune thrombocytopenia, inflammatory bowel disease and susceptibility to infection, cured by HSCT. The immune defect was characterized by defective PI3Kδ signaling, altered T cell metabolism and a prominent infiltrate of cytotoxic lymphocytes in the gut lamina propria. Our experience emphasises the potentially life-threatening nature of immune dysregulation in this condition, albeit we were able to gain short-term control with a cocktail of antiviral and immunosuppressive drugs. By analogy with related conditions such as CTLA4 deficiency and STAT3
gain-of-function, HSCT remains an attractive option in severe immune dysregulation of monogenic origin. In the case of therapy with p110δ-specific small molecule inhibitors, we can conclude that autoimmune phenomena such as colitis arise from the same on-target activity that delivers therapeutic benefit by breaking tolerance to malignancy.
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Whole exome sequencing
Whole exome capture from patient whole blood DNA was achieved using the Agilent SureSelect V5 kit and libraries subsequently prepared for paired-end sequencing. Libraries were sequenced on an Illumina NextSeq instrument by a commercial sequencing provider (Oxford Gene Technology, UK).
Read quality was assessed using the FastQC and MultiQC tools. 
PBMC isolation, generation of T cell lines and T cell maintenance
PBMCs were isolated by means of density centrifugation over Ficoll-Paque and resuspended in complete RPMI media. For T cell expansion, either of the following 2 methods was used: 1) Cells were cultured for 72 hrs in the presence of anti-CD3 (1ug/ml), anti-CD28 (1ug/ml) and IL-2 (20 ng/ml). Once the T cells were differentiated to T cell blasts, a further expansion was done in the presence of IL-2 for another 72-96 hrs. 2) T cells were expanded from 0.3x10 6 total PBMCs by stimulation with phytohaemagglutinin (PHA, 1 μg/mL; Remel) in the presence of 2.5x10 4 irradiated allogeneic (45 Gy) PBMCs and cultured for 21 days in IL-2 containing medium (500 U/mL) as previously described. 4 For the generation of T cell lines, cells were FACS-sorted to >98% purity based on the surface expression of CD3 + CD4 + CD8 -and CD3 + CD8 + CD4 -marker combinations (antibodies used, and surface staining methodology as described in the section "analysis of surface marker expression"). T cells were expanded by culturing 5x10 5 cells in the presence of 2.5x10 4 irradiated (45 Gy) allogeneic PBMCs/50 µl culture for 21 days in medium supplemented with IL-2 (500 U/mL).
Cell sorting was performed using a FACSAria III (BD Biosciences).
T cell lines were cultured thereafter in complete RPMI with L-glutamine (Sigma) supplemented with 5 % (v/v) human serum (NHS Blood Center Oxford), non-essential amino acids (Gibco); 1 mM sodium pyruvate (Gibco) and 100 U/mL penicillin and 10 µg/mL streptomycin (Sigma), hereafter called complete medium. Where indicated 500 U/mL IL-2 was added to the culture medium (produced in house from IL-2T6 culture supernatants).
PIP3 quantification
PIP3 was quantified as described 5 . T cells were isolated from PBMCs using immunomagnetic negative selection kit (Stemcell T cell isolation kit). The purified T cells were stimulated with anti-CD3
(1µg/ml) and anti-CD28 (2µg/ml) antibodies followed by crosslinking with goat anti-mouse IgG
(1:500) antibodies for 1 min at 37˚C. After stimulation of T cells, reactions were terminated by addition of 750 µl kill solution and samples were immediately frozen. Samples were kept in a freezer at -80°C until they were processed. Samples were thawed and 10 µl of C16/C17 PIP2 and PIP3 internal standard (ISD) was added. After 5 min at room temperature, 725 µl CHCl3 and 170 µl 2M HCl were added to the samples. After that, samples were centrifuged and the lower organic phase was collected. 708 µL of pre-derivatisation wash (upper phase) was added, vortexed and samples were centrifuged again. The lower phase was then collected in a fresh tube for derivatisation. 50 µl 2M
TMS-diazomethane was added to the lipid extracts and they were incubated for 10 min at room temperature. The reaction was stopped by addition of 6 µl of glacial acetic acid and the samples were washed twice with 700 µl post-derivatisation buffer (upper phase). After the final wash, 100 µl of MeOH:H2O (9:1) were added to the samples and they were dried under a stream of nitrogen at room temperature. Samples were then re-dissolved in 80 µl of MeOH, sonicated and 20 µl of water was added. The samples were then sent for a mass spectrometry analysis Samples were analysed on a ABSciex QTRAP 4000 connected to a Waters Acquity UPLC system. Integrated area of PIP3 was corrected for recovery against the PIP3 internal standard and then normalized to the integrated area of PIP2 corrected for recovery against the PIP2 internal standard. The Mass spec data are expressed as ratio of the quantity of the intracellular PIP3 divided by that of the PIP3 internal standard and normalized according to the intracellular PIP2 divided by that of the PIP2 internal standard.
Analysis of T cell receptor and IL-2 receptor signaling by immunoblotting
T cell lines were extensively washed before serum starvation for 4h in RPMI medium without supplements. Cells were resuspended at 5 x10 6 cells/mL and aliquoted as 100µl per test tube. Cells were then cooled on ice for 15 min. For cell activation via the TCR, cells were incubated with 1µg/mL OKT3 (Biolegend) and 2µg/mL anti-CD28 on ice for 5 min followed by addition of 5µg/mL goat anti- 
Analysis of transcription factor and perforin expression in PBMC
For the analysis of transcription factor and perforin expression, PBMCs were stained for surface markers as indicated above followed by fixation and permeabilisation using the Transcription Factor Staining Buffer Set (eBioscience) according to the manufacturer's instructions. For the exclusion of dead cells during the analysis, cells were stained prior to fixation using Fixable Viability Dye eFluor® 780. The following fluorophore-conjugated antibodies were used: anti-TBET (Biolegend; clone 4B10), anti-FOXP3 (eBioscience; clone: PCH101), anti-Perforin (Biolegend; clone B-D48).
Samples were acquired on a BD Fortessa or BD LSRII and data were analysed using FlowJo software (Tree Star). Gating was performed using isotype or unstimulated controls.
Metabolic analysis
Glycolysis stress test XFe96 (Agilent technologies) was performed as per manufacturer's protocol.
CD4+ and CD8+ T cell lines were starved of IL-2 for 12 hours in complete medium followed by extensive washing in complete medium. Cells were plated at a density of 250,000 cells per well in
Seahorse base media containing 1% FCS, 2µM glutamine, 1µM sodium pyruvate and 50U/ml of IL-2 (R&D Systems). The plate was then incubated in a CO2-free incubator for one hour. Extracellular acidification rate (ECAR) was recorded at baseline, after glucose, oligomycin and 2-Deoxy-Glucose injection respectively. The assay was performed in technical replicates of 8 and repeated 3 independent times. Glycolysis, glycolytic capacity and glycolytic reserve were calculated as per manufacturer's instructions. Idelalisib (CAL101) treatment was or was not carried out for 48hr on healthy donor CD4+ and CD8+ T cell lines before performing the Seahorse assay as described above.
Immunohistochemistry
Immunohistochemical analysis was performed on formalin-fixed and paraffin-embedded (FFPE) colonic biopsies obtained by colonoscopy. 4μm sections were stained using a Discovery Ultra auto- 
